ECSP088578A - Enzimas para estrés inmunológico reducido - Google Patents

Enzimas para estrés inmunológico reducido

Info

Publication number
ECSP088578A
ECSP088578A EC2008008578A ECSP088578A ECSP088578A EC SP088578 A ECSP088578 A EC SP088578A EC 2008008578 A EC2008008578 A EC 2008008578A EC SP088578 A ECSP088578 A EC SP088578A EC SP088578 A ECSP088578 A EC SP088578A
Authority
EC
Ecuador
Prior art keywords
compositions
animal
enzymes
immune stress
animal feed
Prior art date
Application number
EC2008008578A
Other languages
English (en)
Inventor
David M Anderson
Hung-Yu Hsiao
Lin Liu
Original Assignee
Chemgen Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemgen Corp filed Critical Chemgen Corp
Publication of ECSP088578A publication Critical patent/ECSP088578A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/189—Enzymes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/70—Feeding-stuffs specially adapted for particular animals for birds
    • A23K50/75—Feeding-stuffs specially adapted for particular animals for birds for poultry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405—Glucanases
    • C12N9/2434—Glucanases acting on beta-1,4-glucosidic bonds
    • C12N9/244—Endo-1,3(4)-beta-glucanase (3.2.1.6)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2477—Hemicellulases not provided in a preceding group
    • C12N9/2488—Mannanases
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2477—Hemicellulases not provided in a preceding group
    • C12N9/2488—Mannanases
    • C12N9/2494—Mannan endo-1,4-beta-mannosidase (3.2.1.78), i.e. endo-beta-mannanase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01006—Endo-1,3(4)-beta-glucanase (3.2.1.6)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01014—Chitinase (3.2.1.14)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01039—Glucan endo-1,3-beta-D-glucosidase (3.2.1.39)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01078—Mannan endo-1,4-beta-mannosidase (3.2.1.78), i.e. endo-beta-mannanase

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Animal Husbandry (AREA)
  • Birds (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Transplantation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención se refiere composiciones adecuadas para administración oral a un mamífero que comprende, al menos una enzima que reduce el estrés inmune en una cantidad efectiva para reducir el nivel de proteína de fase aguda positiva en un animal, incrementar el nivel de proteína de fase aguda negativa en un animal, y/o mejorar el desempeño de crecimiento del animal, como son métodos para usar tales composiciones. Las composiciones incluyen composiciones de alimento animal, composiciones líquidas distintas del alimento animal, y composiciones sólidas distintas del alimento animal.
EC2008008578A 2005-12-15 2008-06-23 Enzimas para estrés inmunológico reducido ECSP088578A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US75033905P 2005-12-15 2005-12-15

Publications (1)

Publication Number Publication Date
ECSP088578A true ECSP088578A (es) 2008-10-31

Family

ID=38218427

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2008008578A ECSP088578A (es) 2005-12-15 2008-06-23 Enzimas para estrés inmunológico reducido

Country Status (35)

Country Link
US (5) US7914782B2 (es)
EP (2) EP2263685A3 (es)
JP (1) JP5189989B2 (es)
KR (2) KR101454032B1 (es)
CN (3) CN102293323A (es)
AR (1) AR057247A1 (es)
AT (1) ATE497779T1 (es)
AU (1) AU2006329927B2 (es)
BR (1) BRPI0620155B1 (es)
CA (1) CA2633066C (es)
CL (1) CL2011000941A1 (es)
CR (1) CR10116A (es)
DE (1) DE602006020074D1 (es)
DK (1) DK1973561T3 (es)
EC (1) ECSP088578A (es)
ES (1) ES2361819T3 (es)
GT (1) GT200600512A (es)
HN (1) HN2008000906A (es)
HR (1) HRP20080319B1 (es)
IL (2) IL192088A (es)
IN (1) IN2008DE06112A (es)
MX (1) MX284326B (es)
MY (1) MY145870A (es)
NO (1) NO340818B1 (es)
NZ (1) NZ569186A (es)
PE (1) PE20070840A1 (es)
PL (1) PL1973561T3 (es)
PT (1) PT1973561E (es)
RU (1) RU2465005C2 (es)
SI (1) SI1973561T1 (es)
SV (1) SV2008002942A (es)
TW (2) TWI619506B (es)
UA (1) UA95266C2 (es)
WO (1) WO2007075343A2 (es)
ZA (1) ZA200805780B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY145870A (en) * 2005-12-15 2012-05-15 Lilly Co Eli Enzymes for reduced immunological stress
CA2864887C (en) * 2012-02-16 2017-04-25 Eli Lilly And Company Methods and compositions for reducing the environmental impact of animal waste
WO2015011276A1 (en) * 2013-07-26 2015-01-29 Novozymes A/S POLYPEPTIDES HAVING α-L-GALACTOSIDASE ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME
US10392639B2 (en) * 2014-03-21 2019-08-27 Dsm Ip Assets B.V. Process for the treatment of yeast cell walls with a laminaripentaose producing beta-1,3-glucanase
CN106771257A (zh) * 2017-01-24 2017-05-31 北京美正生物科技有限公司 一种检测血清淀粉样蛋白a的酶联免疫吸附试剂盒及其制备方法和用途
CN107156522A (zh) * 2017-06-23 2017-09-15 都匀市山郎科技养殖有限公司 一种鸡饲料
BE1030865B1 (nl) * 2022-09-12 2024-04-09 Nu3Guts Bv Voederadditief voor het verbeteren van de darmgezondheid en/of de verteerbaarheid van voeder in vee
WO2025099136A2 (en) * 2023-11-10 2025-05-15 Kerry Group Services International Limited Nucleases in animal feed

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58201949A (ja) * 1982-05-17 1983-11-25 Kyodo Shiryo Kk 家畜用配合飼料
US5372939A (en) * 1991-03-21 1994-12-13 The United States Of America As Represented By The United States Department Of Energy Combined enzyme mediated fermentation of cellulous and xylose to ethanol by Schizosaccharoyces pombe, cellulase, β-glucosidase, and xylose isomerase
JP2942384B2 (ja) * 1991-06-07 1999-08-30 株式会社ヤクルト本社 飼料効率改善添加剤
GB2261877A (en) * 1991-11-21 1993-06-02 Kyowa Hakko Kogyo Kk Animal feed additive comprising enzyme and amino acid
WO1995005455A1 (en) * 1993-08-13 1995-02-23 Rijksuniversiteit Te Groningen Pharmaceutical composition comprising phosphatase or a derivative thereof
US5861271A (en) 1993-12-17 1999-01-19 Fowler; Timothy Cellulase enzymes and systems for their expressions
EP1142485B1 (en) 1994-04-22 2008-02-27 Novozymes A/S A method for improving the solubility of vegetable proteins
GB9416841D0 (en) * 1994-08-19 1994-10-12 Finnfeeds Int Ltd An enzyme feed additive and animal feed including it
MY134684A (en) * 1995-05-15 2007-12-31 Gist Brocades Bv Application of phospholipases in animal feed
JP2001057852A (ja) * 1995-06-14 2001-03-06 Showa Denko Kk 耐熱酵素含有飼料用組成物
US5807694A (en) * 1995-09-07 1998-09-15 Economic Innovation And Technology Council, University Of Manitoba Detection of salmonella enteritidis and other pathogenic microorganisms and monoclonal antibody useful therefor
DE69621146T2 (de) * 1995-11-06 2002-11-28 Novozymes A/S, Bagsvaerd Verwendung von Galactanase in Tierfutter
EP0904359A1 (en) * 1996-04-12 1999-03-31 Novo Nordisk A/S AN ENZYME WITH $g(b)-1,3-GLUCANASE ACTIVITY
CN1092495C (zh) 1996-05-03 2002-10-16 开姆根有限公司 半纤维素酶在低热焓饲料中的应用
US6162473A (en) 1996-05-03 2000-12-19 Chemgen Corporation Hemicellulase use in feeds with low caloric content
US20020164751A1 (en) * 1996-06-19 2002-11-07 Short Jay M. Enzymes having thermostable phosphatase activity and methods of use thereof
GB9623539D0 (en) * 1996-11-12 1997-01-08 Biotal Ltd Enzymes and their use
GB2327345B (en) 1997-07-18 1999-06-23 Finnfeeds Int Ltd Use of an enzyme for manufacturing an agent for controlling bacterial infection
US6022566A (en) * 1997-12-02 2000-02-08 Balchem Corporation Method for increasing the feed intake, feed efficiency, daily gain and/or carcass grade in ruminants
EP0976838A1 (en) * 1998-05-06 2000-02-02 Rhone-Poulenc Nutrition Animale Enzymes mixture
US6331426B1 (en) * 1999-02-11 2001-12-18 Novozymes A/S Bacterial galactanases and use thereof
US6213930B1 (en) * 1999-03-15 2001-04-10 Wisconsin Alumni Research Foundation Method of using anti-phospholipase A2 antibodies to enhance growth or improve feed efficiency
US6500658B1 (en) * 1999-08-17 2002-12-31 Novozymes, A/S Xyloglucanase from Malbranchea
UA78486C2 (uk) * 1999-12-10 2007-04-10 Хемджен Корпорейшн Композиція для перорального введення птахам та тваринам для лікування або зниження ризику інфекції травного тракту (варіанти), її застосування (варіанти) та спосіб лікування або зниження ризику інфекцій травного тракту (варіанти)
GB0010748D0 (en) 2000-05-05 2000-06-28 Brown Paul D Tricep exercise horse (fold up and portable)
AU2001269923A1 (en) * 2000-06-19 2002-01-02 Genzyme Corporation Combination enzyme replacement, gene therapy and small molecule therapy for lysosomal storage diseases
GB2371013B (en) 2001-01-16 2004-06-09 Terry John Claydon Copying apparatus
CA2440317A1 (en) * 2001-01-17 2002-07-25 Ramot At Tel Aviv University Ltd. Chitinases, derived from carnivorous plants polynucleotide sequences encoding thereof, and methods of isolating and using same
DE10105306A1 (de) * 2001-02-02 2002-08-22 Nutrinova Gmbh Futtermittel für die Nutztieraufzucht enthaltend Sorbinsäure und Enzyme
DE10105347A1 (de) * 2001-02-05 2002-08-22 Nutrinova Gmbh Sorbinsäurepräparat enthaltend Probiotika als Futtermittelzusatz in der Nutztieraufzucht
IE20011100A1 (en) * 2001-12-21 2003-07-09 Vsl Pharma Ltd Analytical Method for Detecting Alkaline Sphingomyelinase and Kit for Use in Such Method
US20060193843A1 (en) * 2002-01-25 2006-08-31 Dsm Ip Assets B.V. Thermostable enzyme compositions
AU2003304239A1 (en) * 2002-11-13 2005-01-13 Yvonne J. Rosenberg A pretreatment or post exposure treatment for exposure to a toxic substance by pulmonary delivery (inhaler) of a bioscavenger
AU2003298036A1 (en) 2002-12-12 2004-07-09 Zoltan Laboratories Placental alkaline phosphatase to control diabetes
AU2005210581B2 (en) * 2004-02-04 2010-06-24 Am-Pharma B.V. Use of alkaline phosphatase for the detoxification of LPS present at mucosal barriers
US20110142817A1 (en) * 2004-02-04 2011-06-16 Pharmaaware Sepsis B.V. Means and method for treating and/or preventing necrotizing enterocolitis
WO2005094874A1 (en) * 2004-04-01 2005-10-13 Zymenex A/S Medical use of alpha-mannosidase
JP4977124B2 (ja) * 2005-03-25 2012-07-18 ウニベルズィタイト・ヘント フラボノイド類の酵素的脱メチル化
CN1699576A (zh) * 2005-06-30 2005-11-23 江南大学 一种内切β－1,3葡聚糖酶基因及其克隆方法
WO2007032818A2 (en) * 2005-09-12 2007-03-22 Zoltan Laboratories Llc Compounds and compositions to control abnormal cell growth
MY145870A (en) * 2005-12-15 2012-05-15 Lilly Co Eli Enzymes for reduced immunological stress
CA2716400C (en) * 2008-02-29 2017-05-09 Alloksys Life Sciences B.V. Method for increasing the activity of the immune system of a mammal at risk of inflammatory diseases

Also Published As

Publication number Publication date
BRPI0620155B1 (pt) 2015-07-21
HRP20080319B1 (hr) 2015-11-20
PL1973561T3 (pl) 2011-08-31
NZ569186A (en) 2011-09-30
JP5189989B2 (ja) 2013-04-24
US7914782B2 (en) 2011-03-29
US20110177195A1 (en) 2011-07-21
GT200600512A (es) 2007-06-28
SI1973561T1 (sl) 2011-07-29
AU2006329927B2 (en) 2011-09-29
US20170156371A1 (en) 2017-06-08
US20110171344A1 (en) 2011-07-14
ATE497779T1 (de) 2011-02-15
IL227318A (en) 2016-11-30
US20110171345A1 (en) 2011-07-14
MX2008007735A (en) 2008-08-27
SV2008002942A (es) 2008-12-03
PT1973561E (pt) 2011-05-12
AR057247A1 (es) 2007-11-21
RU2465005C2 (ru) 2012-10-27
CN101374544A (zh) 2009-02-25
TW201336425A (zh) 2013-09-16
CA2633066A1 (en) 2007-07-05
CN102293323A (zh) 2011-12-28
RU2008128583A (ru) 2010-01-20
WO2007075343A3 (en) 2007-10-04
TWI402039B (zh) 2013-07-21
MX284326B (en) 2011-03-01
EP1973561B1 (en) 2011-02-09
IL192088A (en) 2013-07-31
TW200731932A (en) 2007-09-01
US8778648B2 (en) 2014-07-15
KR101454032B1 (ko) 2014-10-27
IL192088A0 (en) 2009-02-11
ES2361819T3 (es) 2011-06-22
CL2011000941A1 (es) 2014-08-08
DK1973561T3 (da) 2011-05-23
KR20080081972A (ko) 2008-09-10
CA2633066C (en) 2015-01-20
BRPI0620155A2 (pt) 2011-11-01
CN101374544B (zh) 2016-05-18
KR20130082514A (ko) 2013-07-19
CN105831428B (zh) 2020-12-01
PE20070840A1 (es) 2007-08-25
WO2007075343A2 (en) 2007-07-05
NO340818B1 (no) 2017-06-26
EP2263685A2 (en) 2010-12-22
EP2263685A3 (en) 2011-04-06
AU2006329927A1 (en) 2007-07-05
KR101399205B1 (ko) 2014-05-27
CR10116A (es) 2008-10-28
CN105831428A (zh) 2016-08-10
EP1973561A2 (en) 2008-10-01
NO20083035L (no) 2008-09-11
HRP20080319A2 (hr) 2008-12-31
IN2008DE06112A (es) 2008-09-26
JP2009519712A (ja) 2009-05-21
TWI619506B (zh) 2018-04-01
ZA200805780B (en) 2009-03-25
MY145870A (en) 2012-05-15
HN2008000906A (es) 2011-07-12
UA95266C2 (uk) 2011-07-25
US20070141041A1 (en) 2007-06-21
DE602006020074D1 (de) 2011-03-24

Similar Documents

Publication Publication Date Title
CR10116A (es) Enzimas para estres inmunólogico reducido
CO2019014682A2 (es) Composiciones y métodos para enzimas de internalización
ES2568803T3 (es) Reducción del contenido de ácidos grasos saturados en semillas de plantas
BR112014014834A2 (pt) composições para cuidado oral
CL2012003656A1 (es) Uso de una composicion que comprende una enzima de reemplazo para la enzima lisosomal a una concentracion mayor a 5 mg/ml para tratar sintomas somaticos de la deficiencia de la enzima subyacente.
NI201200089A (es) INHIBIDORES DE N1 - PIRAZOLOESPIROCETONA ACETIL - CoA CARBOXILASA.
EA201992247A1 (ru) Быстрая и контролируемая доставка композиций с восстановленным эффектом антуража
WO2013029013A8 (en) Enzyme producing bacillus strains
MX373157B (es) Metodos de extincion mejorados para la inactivacion de patogenos en globulos rojos.
MX2010004674A (es) Variantes de alfa-amilasa con propiedades alteradas.
MX337028B (es) Eliminacion de serina proteasas por tratamiento con dioxido de silicona finamente dividido.
AR101961A1 (es) Composiciones que comprenden células recombinantes de bacillus y otro agente de control biológico
AR078346A1 (es) Anticuerpos humanos de alta afinidad contra el receptor activado por proteasa de tipo 2 humano
UY30816A1 (es) Compuestos activos en proteina quinasa, composicionesconteniéndolos y plicaciones
EA201190170A1 (ru) Композиции полимера мирцена
BR112013027307A2 (pt) método para tratar uma matriz de tecido; matriz de tecido acelular
AR090465A1 (es) Formas solidas de un profarmaco de nucleotidos de tiofosforamidato
PE20140190A1 (es) Moduladores de proteinas notum y metodos de uso
CL2012001800A1 (es) Método para incrementar la producción de cultivos, que comprende administrar a una planta de cultivo una composicion que comprende 95% de 9-beta-d-adenosina; composicion que comprende dicho compuesto y un fertilizante.
MX2019004487A (es) Metodos y composiciones para el tratamiento de la enfermedad de fabry.
EA201170703A1 (ru) Производные адамантилбензамида
NI200800176A (es) Uso de derivados de sulfamidas heterocíclicas benzo-fusionadas para el tratamiento de la depresión
CL2021000005A1 (es) Tiofencarboxamidas sustituidas y análogos de las mismas
AR054525A1 (es) Composiciones y metodos para eltratamiento de sintomas relacionados con el ciclo
AR046123A1 (es) Aislamiento de celulas simil-celulas madre, uso de las mismas